SEC Company Response from CytoDyn Inc. (CYDY) (CIK 0001175680) (CYDY) — May 6, 2020
CytoDyn Inc. (CYDY) (CIK 0001175680)
Date: May 6, 2020 · CIK: 0001175680 · Accession: 0001193125-20-135276
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-236198
Letter
CytoDyn Inc.
1111 Main Street, Suite 660
Vancouver, Washington 98660
May 6,
VIA EDGAR SUBMISSION
United States Securities and Exchange Commission
Division of Corporation Finance
F Street, NE
Washington, DC 20549
Re: REQUEST FOR ACCELERATION OF EFFECTIVENESS
CytoDyn Inc.
Registration Statement on Form S-3
File No. 333-236198
Ladies and Gentlemen:
CytoDyn Inc. (the “Company”) hereby respectfully requests the acceleration of the effectiveness of the above-referenced Registration Statement (the “Registration Statement”) so that the Registration Statement will become effective at 4:30 p.m. (Eastern time) on Monday, May 11, 2020, or as soon thereafter as practicable.
The Company requests the Commission confirm the effective date and time of the Registration Statement to Kara Tatman of Perkins Coie LLP, counsel to the Company, by telephone at (503) 727-2171.
Very truly yours,
CytoDyn Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver, Washington 98660 May 6, 2020 VIA EDGAR SUBMISSION United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Re: REQUEST FOR ACCELERATION OF EFFECTIVENESS CytoDyn Inc. Registration Statement on Form S-3 File No. 333-236198 Ladies and Gentlemen: CytoDyn Inc. (the “Company”) hereby respectfully requests the acceleration of the effectiveness of the above-referenced Registration Statement (the “Registration Statement”) so that the Registration Statement will become effective at 4:30 p.m. (Eastern time) on Monday, May 11, 2020, or as soon thereafter as practicable. The Company requests the Commission confirm the effective date and time of the Registration Statement to Kara Tatman of Perkins Coie LLP, counsel to the Company, by telephone at (503) 727-2171. Very truly yours, CytoDyn Inc. /s/ Michael D. Mulholland Michael D. Mulholland Interim Chief Financial Officer cc: Kara Tatman (Perkins Coie LLP)